View Post

A pill for breast cancer? There’s one for early-stage patients with aggressive cases — and it works

In In The News by Barbara Jacoby

By: Peter Loftus, Wall Street Journal From: geneticliteracyproject.org A drug sold by AstraZeneca and Merck & Co. reduced the recurrence of breast cancer in women with an early but aggressive form of the disease, a long-running international study found. The finding, which on [June 3] was published online by the New England Journal of Medicine and released at a major …